@incollection{,
	
					
					
					266E83840D0B2CBF491D391914E3DC21
				,
	author={{MosesKayode} and {University of Ibadan.}},
	journal={{Global Journal of Medical Research}},
	journal={{GJMR}}2249-46180975-588810.34257/GJMR,
	address={Cambridge, United States},
	publisher={Global Journals Organisation}1252736
}

@book{b0,
	
	
		,
	title={{Diabetes mellitus in: Therapeutic Basis of Clinical Pharmacy in the Tropics}}
		,
	author={{
			CNAguwa
		} and {
			MKOmole
		}}
		
		
			,
	year={2004}
			
		
	
	,
	note={3rd Edition}

}

@incollection{b1,
	
	
		,
	title={{Screening for Type 2 Diabetes}}
	
	
		,
	journal={{Diabetes care}}
		
			27
			133
			,
	year={2004. 2004}
			,
	publisher={American Diabetes Association}
		
	

}

@incollection{b2,
	
	
		,
	title={{}}
	
	
		,
	journal={{British Medical Association and Royal Pharmaceutical Society of Great Britain}}
		
			,
	year={2003}
		
	

}

@book{b3,
	
	
		,
	title={{}}
		,
	author={{
			LTCutis
		} and {
			ACharles
		} and {
			WReasner
		} and {
			LIsley
		}}
		
		
		
		
			,
	year={2005}
		
	

}

@incollection{b4,
	
	
	
	
		,
	booktitle={{Pathophysiologic Approach; in: Endocrine Disorders; Diabetes Mellitus. 6 th Edition; Mac Graw Hill Companies}}
				U.S.A.
		
			
		
	

}

@incollection{b5,
	
	
		,
	title={{}}
	
	
		,
	journal={{Diabetes Control and Complications Trials Research Group}}
		
			,
	year={1998}
		
	

}

@incollection{b6,
	
	
		,
	title={{The Effects of Intensive Treatment on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus}}
	
	
		,
	journal={{England Journal of Medicine}}
		
			329
			
			,
	year={1993}
		
	

}

@book{b7,
	
	
		,
	title={{}}
		,
	author={{
			OOEnwere
		} and {
			BLSalako
		} and {
			C OFalade
		}}
		
		
		
			,
	year={2006}
		
	

}

@incollection{b8,
	
	
		,
	title={{Prescription and Cost Consideration at a Diabetic Clinic in Ibadan}}
	
	
		,
	journal={{Annals Of Ibadan Postgraduate Medicine}}
		
			4
			
		
	
	,
	note={Report}
	,
	note={Nigeria: A}

}

@book{b9,
	
	
		,
	title={{}}
		,
	author={{
			JEriksson
		} and {
			AFransilla-Kallunki
		} and {
			AEkstrand
		}}
		
		
		
			,
	year={1995}
		
	

}

@incollection{b10,
	
	
		,
	title={{Early Metabolic Defects in Persons at Increased Risk of Non-Insulin Dependent Diabetes Mellitus}}
	
	
		,
	journal={{N. Engl Med}}
		
			321
			
		
	

}

@book{b11,
	
	
		,
	title={{}}
		,
	author={{
			TKhodabandehlou
		} and {
			LeDerehat
		} and {
			C
		}}
		
		
		
			,
	year={2004}
		
	

}

@incollection{b12,
	
	
		,
	title={{Hemorhological Disturbances as Markers of Diabetic Foot Syndrome Deterioration}}
	
	
		,
	journal={{Clin. Hemorrheol Microcirc}}
		
			30
			
		
	

}

@book{b13,
	
	
		,
	title={{}}
		,
	author={{
			Nyenwe
		}}
		
			,
	year={2003}
		
	

}

@incollection{b14,
	
	
		,
	title={{Type 2 Diabetes in Adult Nigerians: A Study Of Its Prevalence and Risk Factors}}
	
	
		,
	journal={{Diabetes Research and Clinical Practice}}
		
			62
			
			,
	year={2003}
		
	

}

@book{b15,
	
	
		,
	title={{}}
		,
	author={{
			MKOmole
		} and {
			EBello
		}}
		
		
			,
	year={2011}
		
	

}

@incollection{b16,
	
	
		,
	title={{Assessment With Case Studies the Rational Use of Drugs Among Patients With Ischaemic Heart Disease at a Tertiary Hospital In Southwest Nigeria}}
	
	
		,
	journal={{Journal of Pharmaceutical and Medical Sciences}}
		
			1
			5
			
		
	

}

@book{b17,
	
	
		,
	title={{}}
		,
	author={{
			AHPriscilla
		} and {
			KPamela
		}}
		
		
			,
	year={2010}
		
	

}

@incollection{b18,
	
	
		,
	title={{Type 2 Diabetes Comorbidities and Treatment Challenges: Rationale for DPP-4 Inhibitors}}
	
	
		,
	journal={{Postgraduate Medicine}}
		
			122
			78
		
	

}

@incollection{b19,
	
	
		,
	title={{Role of Insulin Resistance in Human Disease}}
		,
	author={{
			GMReaven
		}}
	
	
		,
	journal={{Diabetes}}
		
			37
			
			,
	year={1998. 1998}
		
	

}

@incollection{b20,
	
	
		,
	title={{}}
	
	
		,
	journal={{Standard Treatment Guidelines for Nigeria}}
		
			,
	year={2008}
		
	

}

@book{b21,
	
	
		,
	title={{Endocrine System}}
		
			
		
	

}

@book{b22,
	
	
		,
	author={{
			MStephen
		} and {
			JohnRSetter
		} and {
			JrWhite
		} and {
			RKeithCampbell
		}}
		
		
		
		,
	title={{Textbook of Therapeutics : Drug and Disease Management}}
				Philadelphia, Pensylvania, USA: Lippincott, Williams and Wilkins
		
			,
	year={2000}
			8
			
		
	
	,
	note={th Edition}

}

@book{b23,
	
	
		,
	title={{}}
		,
	author={{
			CTStrev
		} and {
			PNChander
		} and {
			RRocha
		} and {
			AZuckerman
		}}
		
		
		
		
			,
	year={1998}
		
	

}

@incollection{b24,
	
	
		,
	title={{}}
	
	
		,
	journal={{Non-epithelial Effects of Aldosterone. Current Opinion in Endocrinology and Diabetes}}
		
			5
			
		
	

}

@book{b25,
	
	
		,
	title={{Prospective Diabetes Study (UKPDS) Group}}
		,
	author={{
			U
		}}
		
			,
	year={1998}
		
	

}

@incollection{b26,
	
	
		,
	title={{Tight Blood Pressure Control And Risk Of Macrovascular And Microvascular Complications In Type 2 Diabetes (UKPDS 38)}}
	
	
		,
	journal={{British medical journal}}
		
			317
			
		
	

}

@incollection{b27,
	
	
		,
	title={{Effect of Intensive Blood-Glucose Control with Metformin on Complications in Overweight Patients with Type 2 Diabetes (UKPDS 34)}}
	
	
		,
	journal={{Lancet}}
		
			352
			
			,
	year={1998}
		
		
			U.K. Prospective Diabetes Study Group
		
	

}

@incollection{b28,
	
	
		,
	title={{}}
		,
	author={{
			UK
		}}
	
	
		,
	journal={{Prospective Diabetes Study Group}}
		
			,
	year={1998}
		
	

}

@incollection{b29,
	
	
		,
	title={{Intensive Blood Glucose Control with Sulphonylureas or Insulin Compared with Conventional Treatment and Risk of Complications in Patients with Type 2 Diabetes (UKPDS 33)}}
	
	
		,
	journal={{Lancet}}
		
			352
			
		
	

}

@incollection{b30,
	
	
		,
	title={{}}
		,
	author={{
			UK
		}}
	
	
		,
	journal={{Prospective Diabetes Study Group}}
		
			,
	year={1998}
		
	

}

@incollection{b31,
	
	
		,
	title={{Tight Blood Pressure Control and Risk of Macrovascular and Microvascular Complications in Type 2 Diabetes (UKPDS 38)}}
	
	
		,
	journal={{Br Med J}}
		
			317
			
		
	

}

@incollection{b32,
	
	
		,
	title={{-29. World Health Organisation}}
	
	
		,
	booktitle={{Report of the Conference of Experts}}
				Nairobi, Kenya; Geneva
		
			,
	year={1985. November 25. 1999}
			23
			
		
	
	,
	note={Rational Use of Drugs}

}

@book{b33,
	
	
		,
	title={{Report of a WHO consultation: Part 1: Diagnosis and Classification of Diabetes mellitus}}
		
	
	,
	note={Diagnosis and Classification of Diabetes mellitus and its Complications}

}

@book{b34,
	
	
		,
	title={{}}
		,
	author={{
			WhoGeneva
		}}
		
			,
	year={1999}
		
	

}

@incollection{b35,
	
	
		,
	title={{Promoting the Rational use of Drugs in: Drugs and Therapeutics committees-A Practical Guide}}
	
	
		,
	journal={{WHO}}
		
			
			,
	year={2003}
		
	

}

@book{b36,
	
	
		,
	title={{Diabetes Facts and Figures}}
		
		
			,
	year={August 21. 2011. August 21, 2011}
		
	

}

@incollection{b37,
	
	
		,
	title={{}}
	
	
		,
	journal={{Hypertension}}
		
			23
			70
			,
	year={1994. 1994}
		
		
			The National High Blood Pressure Education Programme Working Group
		
	
	,
	note={Report on diabetes}

}

@book{b38,
	
	
		15/07/10 (10.00p
		,
	title={{Glimepiride 2mg 30mins Pre-breakfast. Metformin 500mg 8-hourly}}
				
	

}

@book{b39,
	
	
		,
	title={{Mixtard 28IU morning, 22IU evening 30 mins before meals}}
		,
	author={{
			InsulinSc
		}}
		
	

}

@book{b40,
	
	
		,
	title={{Mixtard 28IU in the morning, 22IU in the evening 30 mins before meals}}
		,
	author={{
			InsulinSc
		}}
		
	

}

@incollection{b41,
	
	
		,
	title={{}}
	
	
		,
	journal={{Basal bolus Insulin}}
		
			
		
	

}

@incollection{b42,
	
	
		,
	title={{}}
	
	
		,
	journal={{Bedtime Sc. NPH 15IU Metformin}}
		
			
		
	

}

@incollection{b43,
	
	
		,
	title={{}}
	
	
		,
	journal={{Basal bolus Insulin}}
		
			
		
	

}

@incollection{b44,
	
	
		,
	title={{}}
	
	
		,
	journal={{Bedtime Sc. NPH 18IU. Metformin}}
		
			1
			12
		
	

}